US Bancorp DE Purchases 2,411 Shares of Integer Holdings Co. (NYSE:ITGR)
US Bancorp DE increased its position in Integer Holdings Co. (NYSE:ITGR – Get Rating) by 23.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,689 shares of the medical equipment provider’s stock after acquiring an additional 2,411 shares during the quarter. US Bancorp DE’s holdings in Integer were worth $789,000 at the end of the most recent quarter.
→ The Coming Copper Bull Run (From Investing Trends)
Several other hedge funds and other institutional investors also recently bought and sold shares of ITGR. Franklin Resources Inc. grew its position in Integer by 38.9% in the 2nd quarter. Franklin Resources Inc. now owns 2,722,621 shares of the medical equipment provider’s stock worth $192,381,000 after purchasing an additional 762,579 shares during the last quarter. Victory Capital Management Inc. grew its position in Integer by 95.5% in the 2nd quarter. Victory Capital Management Inc. now owns 867,575 shares of the medical equipment provider’s stock worth $61,303,000 after purchasing an additional 423,888 shares during the last quarter. Hodges Capital Management Inc. acquired a new stake in Integer in the 2nd quarter worth $4,317,000. Vanguard Group Inc. grew its position in Integer by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 3,635,569 shares of the medical equipment provider’s stock worth $292,918,000 after purchasing an additional 48,145 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership acquired a new stake in Integer in the 1st quarter worth $3,846,000. 98.42% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at Integer
In other news, CEO Joseph W. Dziedzic purchased 4,000 shares of the business’s stock in a transaction that occurred on Friday, December 16th. The stock was purchased at an average cost of $61.95 per share, with a total value of $247,800.00. Following the acquisition, the chief executive officer now directly owns 122,378 shares of the company’s stock, valued at approximately $7,581,317.10. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.01% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
Several analysts have issued reports on ITGR shares. Benchmark decreased their price target on shares of Integer to $90.00 in a research report on Tuesday, November 1st. KeyCorp decreased their target price on shares of Integer from $97.00 to $84.00 and set an “overweight” rating on the stock in a research report on Thursday, October 6th. Finally, StockNews.com began coverage on shares of Integer in a research report on Wednesday, October 12th. They set a “hold” rating on the stock.
Integer Price Performance
Shares of Integer stock opened at $73.26 on Friday. Integer Holdings Co. has a twelve month low of $50.05 and a twelve month high of $88.58. The firm has a market cap of $2.43 billion, a P/E ratio of 34.07 and a beta of 1.17. The firm’s 50-day simple moving average is $70.53 and its 200-day simple moving average is $66.77. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.74 and a current ratio of 2.80.
Integer (NYSE:ITGR – Get Rating) last announced its quarterly earnings results on Thursday, October 27th. The medical equipment provider reported $0.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.06. Integer had a net margin of 5.47% and a return on equity of 9.24%. The firm had revenue of $342.68 million during the quarter, compared to the consensus estimate of $343.15 million. As a group, research analysts expect that Integer Holdings Co. will post 3.77 EPS for the current fiscal year.
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to firstname.lastname@example.org.
Before you consider Integer, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Integer wasn’t on the list.
While Integer currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.